Teva Pharmaceutical Industries Ltd ADR buy The Goldman Sachs Group, Inc.
Start price
06.06.25
/
50%
€15.15
Target price
06.06.26
€20.97
Performance (%)
67.66%
Price
12.12.25
€25.40
Summary
This prediction is currently active. With a performance of 67.66% the BUY prediction by The_Goldman_Sachs_Gr is a big success. This prediction currently runs until 06.06.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Teva Pharmaceutical Industries Ltd ADR | 3.673% | 3.673% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Teva Pharmaceutical Industries Ltd ADR diskutieren
Teva Pharmaceutical Industries Limited (NYSE: TEVA) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $24.00 price target on the stock.
Ratings data for TEVA provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Teva Pharmaceutical Industries Ltd ADR
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€24.40
08.12.25
08.12.25
€26.60
08.12.26
08.12.26
4.10%
12.12.25
12.12.25
